Skip to main content

FDB launches two new AI-powered Rx tools at HIMSS26

One system uses spoken information to auto-queue structured prescription orders directly into the EHR for clinician review and approval. The other enables pharmacists to quickly identify medication orders that warrant closer review.
By Bill Siwicki , Managing Editor
Dr. David Delaney of FDB on Rx IT

Dr. David Delaney, president of FDB

Photo: FDB

FDB (First Databank) has at HIMSS26 this week unveiled two new systems that extend its medication intelligence foundation into clinical workflows: FDB Script Agent and FDB VerifyAssist.

Script Agent is an AI-enabled prescription automation agent designed for ambulatory care settings, where clinicians often spend significant time manually entering structured medication orders after patient encounters.

Ambient listening takes action

Available via model context protocol or API integration and anchored in validated FDB drug knowledge, Script Agent is designed to advance ambient listening to the next level by taking action, said Dr. David Delaney, who last month was named president of FDB. Previously he practiced critical care medicine at Beth Israel Deaconess Medical Center, where he also led applied informatics and technology initiatives.

"It uses spoken information captured during patient visits to auto-queue structured prescription orders directly into the electronic health record for clinician review and approval," he explained. "The agent reduces manual effort while preserving clinical judgment and consistency. Early adopters are projecting meaningful reductions of 70% in prescribing-related documentation time and high prescriber satisfaction.

"VerifyAssist reduces the burden of inpatient pharmacy order verification – which can consume 30-40% of a hospital pharmacist's time – by surfacing the most important drug-specific verification criteria against each patient's current clinical data at the point of verification," he continued. "This helps pharmacists quickly identify medication orders that warrant closer review."

Together, these systems reflect a coordinated, system-level approach that allows intelligence to carry more of the load across the end-to-end medication workflow, he added.

Free your mind

Delaney said FDB's message to HIMSS26 attendees is captured in the company's theme: "Intelligence to Free Your Mind."

"We selected this message because healthcare environments are saturated with alerts, administrative tasks and fragmented workflows," he explained. "Our focus is on reducing unnecessary steps, minimizing interruptions, and embedding medication intelligence directly into the flow of care so clinicians can think more clearly and act more confidently.

"Script Agent and VerifyAssist demonstrate this philosophy in action," he continued. "Script Agent reduces manual prescribing effort while maintaining clinician oversight. VerifyAssist introduces clarity earlier in the verification process, reducing cognitive burden for pharmacists before decisions become urgent. These systems are designed to support clinical judgment, not replace it."

When intelligence works reliably beneath the surface, clinicians can focus on what matters most, he concluded.

FDB is exhibiting at HIMSS26 in booth 3235.

Follow Bill's health IT coverage on LinkedIn: Bill Siwicki
Email him: bsiwicki@himss.org
Healthcare IT News is a HIMSS Media publication.

WATCH NOW: The model context protocol at work in AI and clinical workflows